Shigeki Tatsuno

Shigeki Tatsuno is an M&A/Corporate partner at Anderson Mori & Tomotsune and is well-known as having a thorough knowledge in mergers and acquisitions of listed and unlisted businesses (including, share acquisitions and divestments and business acquisitions and divestments for foreign clients where the target is a Japanese company or business), joint ventures and other cross-border investments, and corporate restructurings.

In addition, he regularly advises a number of venture companies and PE funds in various aspects including start-up, equity finance and initial public offerings, as well as establishing venture capital or other private equity funds, and engages in general corporate matters, including IP transactions, broadly. His clients include reputable international and domestic corporations and investment funds.

Mr Tatsuno has served as a member of the Human Research Ethics Review Committee of Graduate School of Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, The University of Tokyo since 2014 and also served as a member of the External Evaluation Committee for the Program for Promoting the Enhancement of Research Universities (Fiscal 2017), Tokyo Medical and Dental University, with his special expertise in life-science industry. He is qualified in Japan and New York.

Firm Profile

Anderson Mori & Tomotsune is a full-service law firm with more than 450 lawyers qualified in Japan and various jurisdictions around the world, one of the largest international firms in Japan which has been best known for serving overseas companies doing business in Japan since the early 1950s. As a result of this experience, we are quite familiar with every kind of matter faced by non-Japanese companies doing business in Japan. Our main office in Tokyo is supported by our offices in Osaka, Nagoya, Beijing, Shanghai, Singapore, Ho Chi Minh City and Bangkok, as well as a Jakarta Desk.